DRUG
Bright Minds·NASDAQ
--
--(--)
--
--(--)
DRUG Filings
Filing Date
Form Description
Form Type
2025-12-23
Form F-X - Appointment of Agent for Service of Process and Undertaking
2025-12-23 ·
Form F-X - Appointment of Agent for Service of Process and Undertaking
2025-12-23
Form 40-F - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]
Financials
2025-12-23 · Financials
Form 40-F - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]
2025-11-17
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-11-17 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-17
Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
2025-11-17 ·
Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
2025-11-14
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-14 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-13
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-13 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-12
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-12 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-07
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-11-07 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-07
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-11-07 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-09-05
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-09-05 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
